Peter J. O’Dwyer, MD, is the Group Co-Chair of the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) since May 2017. A medical oncologist with expertise in gastrointestinal and pancreatic cancers, Dr. O’Dwyer is a physician at Penn Medicine in Philadelphia, within its Gastrointestinal Cancer Program. He is also a professor of medicine at the Hospital of the University of Pennsylvania and the Presbyterian Medical Center of Philadelphia and director of the Developmental Therapeutics Program at the Abramson Cancer Center.
Within ECOG-ACRIN, Dr. O’Dwyer co-leads the organization’s governance. He also co-chairs the landmark precision medicine cancer trial known as NCI-MATCH (National Cancer Institute-Molecular Analysis for Therapy Choice), chairs the Gastrointestinal Committee, and is a member of several other scientific committees. He co-directs the Cancer Control and Outcomes Program and is a co-principal investigator for two grants from the National Cancer Institute: the NCI Community Oncology Research Program (NCORP) Research Base and the National Clinical Trials Network (NCTN).
Dr. O’Dwyer has more than 250 scientific papers in medical literature and participates in numerous national and international organizations. He is the principal investigator for several University of Pennsylvania grants studying the effectiveness of various cancer treatments. He is board-certified in Internal Medicine, Pediatrics, and Medical Oncology.
He serves as the CEO and Chair of the PrECOG, LLC Board of Managers and President of the ECOG Research and Education Foundation.
Dr. O’Dwyer received his medical degree at the University of Dublin, Trinity College. After an internship, he spent a year of residency at the Hammersmith Hospital in London, followed by pediatric and internal medicine residencies in Connecticut and Maryland. After a fellowship at the Baltimore Cancer Research Center, he became a senior investigator in the Division of Cancer Treatment at the National Cancer Institute, where he also received training in biochemical pharmacology in the laboratory of Dr. Richard Cysyk. At the National Cancer Institute, Dr. O’Dwyer organized a group to study mechanisms of resistance in the clinic and strategies to overcome it. He led the Developmental Therapeutics Program at Fox Chase Cancer Center, and since 1999 has been affiliated with Penn Medicine and the University of Pennsylvania.
|Scientific Planning and Review|
|Biostatistics and Data Management|
|Active Clinical Trials|
|Find a Participating Institution|